[1]KIRYU-SEO S, NAGATA K, SAIDO TC, et al.New insights of a neuronal peptidase DINE/ECEL1:Nerve development, nerve regeneration and neurogenic pathogenesis[J].Neurochem Res, 2018.[Epub ahead of print]
|
[2]KIRYU-SEO S, SASAKI M, YOKOHAMA H, et al.Damageinduced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers[J].Proc Natl Acad Sci USA, 2000, 97 (8) :4345-4350.
|
[3]NAGATA K, TAKAHASHI M, KIRYU-SEO S, et al.Distinct functional consequences of ECEL1/DINE missense mutations in the pathogenesis of congenital contracture disorders[J].Acta Neuropathol Commun, 2017, 5 (1) :83.
|
[4]LI YP, SONG LP, QIU SD, et al.The appliance of lentivirus vector in cancer theray[J].Mod Oncol, 2006, 14 (12) :1615-1617. (in Chinese) 李跃萍, 宋丽萍, 邱曙东, 等.慢病毒载体在肿瘤基因治疗中的应用[J].现代肿瘤医学, 2006, 14 (12) :1615-1617.
|
[5]FRANKEL AD, YOUNG JA.HIV-1:Fifteen proteins and an RNA[J].Annu Rev Biochem, 1998, 67:1-25.
|
[6]WYSOCZYNSKI M, RATAJCZAK MZ.Lung cancer secreted microvesicles:Underappreciated modulators of microenvironment in expanding tumors[J].Int J Cancer, 2009, 125 (7) :1595-1603.
|
[7]ZHANG L, LIU QY, HU T, et al.The construction of high-efficiency packaging system of the 3rd lentivirus[J].Genom Appl Biol, 2009, 28 (2) :326-330. (in Chinese) 张磊, 刘庆友, 胡天, 等.第三代慢病毒高效率包装系统的建立[J].基因组学与应用生物学, 2009, 28 (2) :326-330.
|
[8]BRECKPOT K, AERTS JL, THIELEMANS K.Lentiviral vectors for cancerimmunotherapy:Transforming infectious particles into therapeutics[J].Gene Ther, 2007, 14 (11) :847-862.
|
[9]ESCORS D, BRECKPOT K.Lentiviral vectors in gene therapy:Their current status and future potential[J].Arch Immunol T-her Exp (Warsz) , 2010, 58 (2) :107-119.
|
[10]KAFRI T, BLOMER U, PETERSON DA, et al.Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors[J].Nat Genet, 1997, 17 (3) :314-317.
|
[11]MAO Y, YAN R, LI A, et al.Lentiviral vectors mediate long term and high efficiency transgene expression in hek 293Tcells[J].Int J Med Sci, 2015, 12 (5) :407-415.
|
[12]KAHLERT C, KLUPP F, BRAND K, et al.Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases[J].Cancer Sci, 2011, 102 (10) :1799-1807.
|
[13]LIN Y, DESAI A, GESRSON SL.Lentiviruses:Vectors for cancer gene therapy[M].In:Roth J, editor.Gene Based Therapies for Cancer, Current Cancer Research.Springer Science, 2010.
|
[14]VUCIC D, FAIRBROTHER WJ.The inhibitor of apoptosis proteins as therapeutic targets in cancer[J].Clin Cancer Res, 2007, 13 (20) :5995-6000.
|
[15]KOCK N, KASMIEH R, WEISSLEDER R, et al.Tumor theraphy media-ted by lentiviral expression of sh Bcl-2 and S-TRAIL[J].Neo-plasia, 2007, 9 (5) :435-442.
|
[16]ZHAO B, YANG C, YANG S, et al.Construction of conditional lentivir-Us-mediated shRNA vector targeting the human Mirk gene and identification of RNAi efficiency in rhabdomyosarcoma RD cells[J].Int J Oncol, 2013, 43 (9) :1253-1259.
|
[17]LING X, ARLINGHAUS RB.Knockdown of STAT3 expression by immunocompetent mice[J].Cancer Res, 2015, 65 (7) :2532-2536.
|
[18]SUMIMOTO H, MIYAGISHI M, MIYOSHI H, et al.Inhibition of growth and invasive ability of melanoma RNA interference[J].Oncogene, 2014, 23 (36) :6031-6039.
|
[19]PUTRAL LN, BYWATER MJ, GU W, et al.RNA interference against hunman papilloomavirus oncogenes in cervical cancer cells result in increased sensitivitity to cisplatin[J].Mol Pharmacol, 2015, 68 (5) :1311-1319.
|
[20]YE XS, LIU T, GONG YP, et al.Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 singlefactor resistant cell line K562/MDR1[J].Leuk Res, 2009, 33 (8) :1114-1119.
|
[21]XIE SM, FANG WY, LIU Z, et al.Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin[J].Transl Med, 2008, 6 (1) :55-63.
|